Insider · CIK 0001916577
Fong James K
Reports to the SEC for 1 company · SEATTLE, WA
Transactions
15
Companies
1
Filings
3
CIK
0001916577
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-26 | CTI BIOPHARMA CORPU Disposition from Tender | −$32.4K |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-06-26 | CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-03-14 | CTI BIOPHARMA CORPStock Option (right to buy)A Award | — |
| 2023-01-24 | CTI BIOPHARMA CORPM Exercise/Conversion | +$94.9K |
| 2023-01-24 | CTI BIOPHARMA CORPS Sale | −$600K |
| 2023-01-24 | CTI BIOPHARMA CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-02-19 | CTI BIOPHARMA CORPNon-Qualified Stock Option (right to buy)A Award | — |
Recent filings
- 4Fong James K0000899243-23-016479SEC(opens sec.gov)
- 4Fong James K0000899243-23-008750SEC(opens sec.gov)
- 4Fong James K0000891293-23-000003SEC(opens sec.gov)
Companies
Address
C/O CTI BIOPHARMA CORP. 3101 WESTERN AVENUE, SUITE 800
SEATTLE, WA, 98121